Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -5.63% | -2.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.63% | -2.15% | |||
| Cost of Revenue | -1.83% | -7.77% | |||
| Gross Profit | -7.57% | 0.98% | |||
| SG&A Expenses | -20.33% | 18.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.91% | 6.69% | |||
| Operating Income | 155.86% | -65.54% | |||
| Income Before Tax | 373.26% | -134.66% | |||
| Income Tax Expenses | -40.11% | 163.25% | |||
| Earnings from Continuing Operations | 168.42% | -213.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 168.42% | -213.94% | |||
| EBIT | 155.86% | -65.54% | |||
| EBITDA | 49.16% | -37.93% | |||
| EPS Basic | 167.06% | -213.68% | |||
| Normalized Basic EPS | 367.76% | -134.59% | |||
| EPS Diluted | 165.68% | -214.77% | |||
| Normalized Diluted EPS | 363.14% | -134.79% | |||
| Average Basic Shares Outstanding | 2.04% | 0.22% | |||
| Average Diluted Shares Outstanding | 3.84% | -0.38% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 2.46% | -1.88% | |||